In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other firms post strong gains amid Wall Street bloodbath. Wall Street’s main indices closed ...

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per share.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Pulmonary angiography is a test that studies blood flow in your lungs. Its purpose is to find problems such as pulmonary embolisms (blood clots in your lungs), stenosis (narrowed blood vessels), or ...

Inari Medical, Inc. (NASDAQ:NARI – Get Free Report)’s share price traded down 4.6% during mid-day trading on Monday after an insider sold shares in the company.The stock traded as low as $52. ...

Analysts' ratings for Inari Medical NARI over the last quarter vary from bullish to bearish, as provided by 6 analysts. The following table encapsulates their recent ratings, offering a glimpse ...

As of December 3, 2024, the average one-year price target for Inari Medical is $66.15/share. The forecasts range from a low of $50.50 to a high of $90.30. The average price target represents an ...

Book these experiences for a close-up look at Inari.